Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
The report details the trend, potential and market size of Neuromyelitis Optica Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neuromyelitis Optica Drugmarket, defines the market attractiveness level of Neuromyelitis Optica Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neuromyelitis Optica Drug industry, describes the types of Neuromyelitis Optica Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuromyelitis Optica Drug market and the development prospects and opportunities of Neuromyelitis Optica Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuromyelitis Optica Drug market in Chapter 13.
By Player:
Baxter
TEVA
Tianjin Kingyork
Pfizer
Gyjtrs
SANDOZ
NANG KUANG
Intas
Grifols
CSL
FRESENIUS
CBOP
Octapharma
By Type:
Production Market Share
Price Rage
Cost
By End-User:
Acute attack
Remission prophylactic treatment
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neuromyelitis Optica Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neuromyelitis Optica Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neuromyelitis Optica Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neuromyelitis Optica Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neuromyelitis Optica Drug Market Analysis and Outlook to 2022
-
7.1 Global Neuromyelitis Optica Drug Consumption (2017-2022)
-
7.2 United States Neuromyelitis Optica Drug Consumption (2017-2022)
-
7.3 Europe Neuromyelitis Optica Drug Consumption (2017-2022)
-
7.4 China Neuromyelitis Optica Drug Consumption (2017-2022)
-
7.5 Japan Neuromyelitis Optica Drug Consumption (2017-2022)
-
7.6 India Neuromyelitis Optica Drug Consumption (2017-2022)
-
7.7 South Korea Neuromyelitis Optica Drug Consumption (2017-2022)
8 Region and Country-wise Neuromyelitis Optica Drug Market Analysis and Outlook to 2028
-
8.1 Global Neuromyelitis Optica Drug Consumption Forecast (2022-2028)
-
8.2 United States Neuromyelitis Optica Drug Consumption Forecast (2022-2028)
-
8.3 Europe Neuromyelitis Optica Drug Consumption Forecast (2022-2028)
-
8.4 China Neuromyelitis Optica Drug Consumption Forecast (2022-2028)
-
8.5 Japan Neuromyelitis Optica Drug Consumption Forecast (2022-2028)
-
8.6 India Neuromyelitis Optica Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Neuromyelitis Optica Drug Consumption Forecast (2022-2028)
9 Global Neuromyelitis Optica Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Neuromyelitis Optica Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Production Market Share Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Price Rage Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cost Consumption and Growth Rate (2017-2022)
-
9.2 Global Neuromyelitis Optica Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Acute attack Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Remission prophylactic treatment Consumption and Growth Rate (2017-2022)
10 Global Neuromyelitis Optica Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Neuromyelitis Optica Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Production Market Share Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Price Rage Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Cost Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neuromyelitis Optica Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Acute attack Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Remission prophylactic treatment Consumption Forecast and Growth Rate (2022-2028)
11 Global Neuromyelitis Optica Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neuromyelitis Optica Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neuromyelitis Optica Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neuromyelitis Optica Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neuromyelitis Optica Drug Market Competitive Analysis
-
14.1 Baxter
-
14.1.1 Baxter Company Details
-
14.1.2 Baxter Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Baxter Neuromyelitis Optica Drug Product and Service
-
14.2 TEVA
-
14.2.1 TEVA Company Details
-
14.2.2 TEVA Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 TEVA Neuromyelitis Optica Drug Product and Service
-
14.3 Tianjin Kingyork
-
14.3.1 Tianjin Kingyork Company Details
-
14.3.2 Tianjin Kingyork Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Tianjin Kingyork Neuromyelitis Optica Drug Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Neuromyelitis Optica Drug Product and Service
-
14.5 Gyjtrs
-
14.5.1 Gyjtrs Company Details
-
14.5.2 Gyjtrs Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gyjtrs Neuromyelitis Optica Drug Product and Service
-
14.6 SANDOZ
-
14.6.1 SANDOZ Company Details
-
14.6.2 SANDOZ Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 SANDOZ Neuromyelitis Optica Drug Product and Service
-
14.7 NANG KUANG
-
14.7.1 NANG KUANG Company Details
-
14.7.2 NANG KUANG Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 NANG KUANG Neuromyelitis Optica Drug Product and Service
-
14.8 Intas
-
14.8.1 Intas Company Details
-
14.8.2 Intas Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Intas Neuromyelitis Optica Drug Product and Service
-
14.9 Grifols
-
14.9.1 Grifols Company Details
-
14.9.2 Grifols Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Grifols Neuromyelitis Optica Drug Product and Service
-
14.10 CSL
-
14.10.1 CSL Company Details
-
14.10.2 CSL Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 CSL Neuromyelitis Optica Drug Product and Service
-
14.11 FRESENIUS
-
14.11.1 FRESENIUS Company Details
-
14.11.2 FRESENIUS Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 FRESENIUS Neuromyelitis Optica Drug Product and Service
-
14.12 CBOP
-
14.12.1 CBOP Company Details
-
14.12.2 CBOP Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 CBOP Neuromyelitis Optica Drug Product and Service
-
14.13 Octapharma
-
14.13.1 Octapharma Company Details
-
14.13.2 Octapharma Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Octapharma Neuromyelitis Optica Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neuromyelitis Optica Drug
-
Figure Neuromyelitis Optica Drug Picture
-
Table Global Neuromyelitis Optica Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuromyelitis Optica Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuromyelitis Optica Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neuromyelitis Optica Drug Consumption by Country (2017-2022)
-
Figure United States Neuromyelitis Optica Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Neuromyelitis Optica Drug Consumption and Growth Rate (2017-2022)
-
Figure China Neuromyelitis Optica Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Neuromyelitis Optica Drug Consumption and Growth Rate (2017-2022)
-
Figure India Neuromyelitis Optica Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neuromyelitis Optica Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Neuromyelitis Optica Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Neuromyelitis Optica Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neuromyelitis Optica Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neuromyelitis Optica Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neuromyelitis Optica Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neuromyelitis Optica Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neuromyelitis Optica Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Production Market Share Consumption and Growth Rate (2017-2022)
-
Figure Global Price Rage Consumption and Growth Rate (2017-2022)
-
Figure Global Cost Consumption and Growth Rate (2017-2022)
-
Figure Global Acute attack Consumption and Growth Rate (2017-2022)
-
Figure Global Remission prophylactic treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Production Market Share Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Price Rage Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cost Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acute attack Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Remission prophylactic treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neuromyelitis Optica Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neuromyelitis Optica Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Baxter (Foundation Year, Company Profile and etc.)
-
Table Baxter Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Neuromyelitis Optica Drug Product and Service
-
Table TEVA (Foundation Year, Company Profile and etc.)
-
Table TEVA Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table TEVA Neuromyelitis Optica Drug Product and Service
-
Table Tianjin Kingyork (Foundation Year, Company Profile and etc.)
-
Table Tianjin Kingyork Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tianjin Kingyork Neuromyelitis Optica Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neuromyelitis Optica Drug Product and Service
-
Table Gyjtrs (Foundation Year, Company Profile and etc.)
-
Table Gyjtrs Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gyjtrs Neuromyelitis Optica Drug Product and Service
-
Table SANDOZ (Foundation Year, Company Profile and etc.)
-
Table SANDOZ Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table SANDOZ Neuromyelitis Optica Drug Product and Service
-
Table NANG KUANG (Foundation Year, Company Profile and etc.)
-
Table NANG KUANG Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table NANG KUANG Neuromyelitis Optica Drug Product and Service
-
Table Intas (Foundation Year, Company Profile and etc.)
-
Table Intas Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Neuromyelitis Optica Drug Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Neuromyelitis Optica Drug Product and Service
-
Table CSL (Foundation Year, Company Profile and etc.)
-
Table CSL Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Neuromyelitis Optica Drug Product and Service
-
Table FRESENIUS (Foundation Year, Company Profile and etc.)
-
Table FRESENIUS Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table FRESENIUS Neuromyelitis Optica Drug Product and Service
-
Table CBOP (Foundation Year, Company Profile and etc.)
-
Table CBOP Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CBOP Neuromyelitis Optica Drug Product and Service
-
Table Octapharma (Foundation Year, Company Profile and etc.)
-
Table Octapharma Neuromyelitis Optica Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Neuromyelitis Optica Drug Product and Service
-
